This inventor holds 1 USPTO granted patent. Top assignees: Cold Spring Harbor Laboratory, Sloan-Kettering Institute for Cancer Research. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2000
Title: The Innovations of David G. Wisniewski
Introduction
David G. Wisniewski is a notable inventor recognized for his contributions to the field of cancer research. He is particularly known for his work related to chronic myelogenous leukemia (CML). His innovative approach has led to significant advancements in understanding the molecular mechanisms underlying this disease.
Latest Patents
Wisniewski holds a patent for a human gene/protein involved in chronic myelogenous leukemia. The characteristic of CML is the presence of the chimeric p120^bcr-abl protein, which possesses elevated protein tyrosine kinase activity compared to the normal c-abl tyrosine kinase. Hematopoietic progenitors isolated from CML patients in the chronic phase contain a constitutively tyrosine phosphorylated protein that migrates at approximately 62 kDa by SDS-PAGE. This protein associates with the p120 ras GTPase-activating protein (GAP). The novel protein, called p62^dok (p62 protein downstream of tyrosine kinases), was isolated from a hematopoietic cell line expressing p120^bcr-abl. The association of p62^dok with GAP correlates with its tyrosine phosphorylation. Furthermore, p62^dok is rapidly tyrosine phosphorylated upon activation of the c-kit receptor, implicating it as a component of a signal transduction pathway downstream of receptor tyrosine kinases.
Career Highlights
Throughout his career, Wisniewski has worked with prestigious institutions such as Cold Spring Harbor Laboratory and the Sloan-Kettering Institute for Cancer Research. His research has significantly contributed to the understanding of cancer biology and the development of potential therapeutic strategies.
Collaborations
Wisniewski has collaborated with notable colleagues, including Nicholas A. Carpino and Ryuji Kobayashi. Their combined efforts have further advanced the research in the field of oncology.
Conclusion
David G. Wisniewski's innovative work in cancer research, particularly regarding chronic myelogenous leukemia, has made a lasting impact on the scientific community. His contributions continue to inspire future research and advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile